Conversion disorder in women with the FMR1 premutation
Women with fragile X mental retardation (FMR1) gene premutations (55–200 CGG repeats) were until recently believed to be unaffected. It is now known that up to 8% of older female FMR1 premutation carriers develop fragile X‐associated tremor/ataxia syndrome (FXTAS). Female carriers may also develop p...
Saved in:
Published in | American journal of medical genetics. Part A Vol. 149A; no. 11; pp. 2501 - 2506 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.11.2009
Wiley-Liss |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Women with fragile X mental retardation (FMR1) gene premutations (55–200 CGG repeats) were until recently believed to be unaffected. It is now known that up to 8% of older female FMR1 premutation carriers develop fragile X‐associated tremor/ataxia syndrome (FXTAS). Female carriers may also develop primary ovarian insufficiency, thyroid disease, hypertension, seizures, peripheral neuropathy, and fibromyalgia. We present a 60‐year‐old woman with FMR1 premutation who had depression, anxiety, and conversion disorder with seizures. The FMR1 premutation with its associated mRNA toxicity is postulated as an underlying neurobiological mechanism of conversion symptoms, through functional and structural neural dysconnectivity. © 2009 Wiley‐Liss, Inc. |
---|---|
Bibliography: | How to cite this article: Seritan AL, Schneider A, Olichney JM, Leehey MA, Akins RS, Hagerman RJ. 2009. Conversion disorder in women with the premutation. Am J Med Genet Part A 149A:2501–2506. FMR1 Parts of this work were presented in poster format at the 2nd International Conference on Psychogenic Movement Disorders and Other Conversion Disorders, Washington, D.C., April 2009. ObjectType-Case Study-3 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-2 ObjectType-Feature-2 |
ISSN: | 1552-4825 1552-4833 |
DOI: | 10.1002/ajmg.a.33054 |